You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 286 No. 10, September 12, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sarcopenia—Understanding the Dynamics of Aging Muscle

Ronenn Roubenoff, MD,MHS; Carmen Castaneda, MD,PhD

JAMA. 2001;286:1230-1231.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Sarcopenia is not a disease but rather refers specifically to the universal, involuntary decline in lean body mass that occurs with age, primarily due to the loss of skeletal muscle.1 Sarcopenia has important consequences. The loss of lean body mass reduces function, and loss of approximately 40% of lean body mass is fatal.2-5 Sarcopenia is distinct from wasting—involuntary weight loss due to inadequate intake, which is seen in starvation, advanced cancer, or acquired immunodeficiency syndrome. Sarcopenia also differs from cachexia, a cytokine-driven loss of lean body mass that occurs despite maintenance of weight, which is seen in patients with rheumatoid arthritis, congestive heart failure, or renal failure.6 However, sarcopenia is the backdrop against which the drama of disease is played out: a body already depleted of protein because of aging is less able to withstand the protein catabolism that comes with acute illness or . . . [Full Text of this Article]

Author Affiliation: Nutrition, Exercise Physiology, and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Basal Muscle Amino Acid Kinetics and Protein Synthesis in Healthy Young and Older Men
Elena Volpi, Melinda Sheffield-Moore, Blake B. Rasmussen, and Robert R. Wolfe
JAMA. 2001;286(10):1206-1212.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of short-term GH supplementation and treadmill exercise training on physical performance and skeletal muscle apoptosis in old rats
Marzetti et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008;294:R558-R567.
ABSTRACT | FULL TEXT  

Role of Protein and Amino Acids in the Pathophysiology and Treatment of Sarcopenia
Dreyer and Volpi
J. Am. Coll. Nutr. 2005;24:140S-145S.
ABSTRACT | FULL TEXT  

Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions
Rall and Roubenoff
Rheumatology (Oxford) 2004;43:1219-1223.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.